High Expression of Ubiquitin-Specific Protease 39 and Its Roles in Prognosis in Patients with Hepatocellular Carcinoma

Table 2

Logistic analysis of correlation between USP39 expression and clinical features.

Characteristics	Total (n)	Odds ratio (OR)	value
T stage (T3/T4 vs. T1/T2)	371	1.914 (1.188–3.118)	0.008
N stage (N1 vs. N0)	258	2.773 (0.350–56.463)	0.380
M stage (M1 vs. M0)	272	2.912 (0.368–59.271)	0.357
Pathologic stage (Stage III/IV vs. Stage I/II)	350	2.047 (1.256–3.377)	0.004
Tumor status (with tumor vs. tumor free)	355	1.851 (1.212–2.840)	0.005
Residual tumor (R1/R2 vs. R0)	345	2.166 (0.820–6.348)	0.131
Histologic grade (G3/G4 vs. G1/G2)	369	2.148 (1.399–3.324)	<0.001
Vascular invasion (yes vs. no)	318	1.573 (0.990–2.511)	0.056